| http://www.w3.org/ns/prov#value | - The Senators asked the FDA to disregard efforts which, if implemented, would needlessly delay consumers' access to generic biologics -- drugs that make up an increasingly-large share of the market and treat diseases and conditions such as cancer, Multiple Sclerosis, and rheumatoid arthritis.
|
